Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Physical Function Scores Help Predict Outcomes in Multiple Myeloma Treatment
July 2025
A new study finds that how patients feel and function before starting treatment can help predict how well they’ll respond to multiple myeloma therapies.
Read more
8 May 2025
Menstrual Cycle May Influence Inflammation in Women with Sickle Cell Disease
A recent study has found that women with sickle cell disease experience higher inflammation during the follicular phase of their menstrual cycle, which may explain the timing of pain episodes and offer insight into more personalised care.
7 May 2025
New Treatment Strategy May Boost Survival in T-Cell Lymphomas
A retrospective analysis of global data has found that a specific treatment sequence, starting with small molecule inhibitors and followed by epigenetic modifiers, may significantly improve survival in patients with relapsed or refractory T-cell lymphomas.
5 May 2025
New Castleman Disease Subtype Identified
A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised through the ACCELERATE natural history registry….
4 May 2025
New Blood Test Shows Promise in Predicting Melanoma Recurrence Risk
A new study from the COMBI-AD trial shows that circulating tumour DNA (ctDNA) testing can accurately predict recurrence and survival in stage III melanoma, offering a potential tool for personalising treatment.
1 May 2025
Statins Improve Survival in Leukaemia and Lymphoma Patients on Ibrutinib
Statins may offer unexpected benefits for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
20 Apr 2025
New Model Predicts CAR-T Therapy Outcomes in Non-Hodgkin Lymphoma
A new study introduces InflaMix, a groundbreaking tool that could transform how clinicians assess treatment risk in patients with non-Hodgkin lymphoma…
14 Apr 2025
Multifaceted Anaemia Treatment Improves Recovery in Critically Ill Individuals
A recent trial shows that a multifaceted anaemia treatment bundle improves haemoglobin recovery in critically ill patients, enhancing recovery after surgery or critical illness.
12 Apr 2025
Mental Health Impact in Patients with Lymphoma and Myeloma
A new study shows that more than 50% of patients with newly diagnosed lymphoma or myeloma suffer from anxiety and depression, significantly impacting their quality of life.
Loading posts...
« Previous
1
2
3
4
5
6
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View